Central Serous Retinopathy (CSR) Guide

High yield central serous retinopathy review for NBEO and OKAP: mechanism, acute vs chronic disease, key FA and OCT findings, and exam traps.

Reviewed for accuracyJuly 27, 20263 min read

Three-panel diagram of central serous chorioretinopathy imaging findings: OCT cross-section showing dome-shaped subretinal fluid with a small adjacent pigment epithelial detachment in acute CSCR, fluorescein angiography showing the more common round, sharply demarcated ink blot leak pattern, and fluorescein angiography showing the classic but less common mushroom-shaped smokestack leak pattern

Warm-up

Which choroidal feature is typical of CSC within the pachychoroid spectrum?

Lesson

Central Serous Retinopathy in 30 Seconds

Central serous retinopathy, now more precisely termed central serous chorioretinopathy (CSCR), is characterized by serous detachment of the neurosensory retina caused by choroidal hyperpermeability with secondary retinal pigment epithelium dysfunction. It typically affects men between 20 and 50 years of age, although it can occur in women and older adults, with acute painless central vision distortion. High yield for NBEO and OKAP: know the steroid link and the FA leak pattern.

How Central Serous Chorioretinopathy Develops

Increased choroidal hydrostatic pressure overwhelms the retinal pigment epithelium, producing focal RPE dysfunction that allows serous fluid to accumulate beneath the neurosensory retina. Corticosteroid exposure by any route, oral, inhaled, topical, or intra-articular, is the strongest known association, and discontinuation should be considered whenever medically appropriate in consultation with the prescribing physician. Other classic risk factors include type A personality traits, pregnancy, Cushing syndrome, and obstructive sleep apnea.

Acute vs Chronic Disease

Acute CSCR: single focal leak point on FA, dome shaped subretinal fluid on OCT, most cases resolve spontaneously within approximately 3 months. Exam relevance: expect a stem describing spontaneous resolution and excellent visual prognosis.
Chronic CSCR (diffuse retinal pigment epitheliopathy): multifocal RPE decompensation with persistent or recurrent subretinal fluid beyond approximately 3 months. Exam relevance: look for descending tract (gutter) RPE atrophy tracking inferiorly and a risk of permanent photoreceptor loss.
Chronic CSCR shows more widespread leakage on FA, increased choroidal thickness with pachychoroid features on enhanced depth imaging OCT, and higher recurrence risk than acute disease. Exam relevance: this distinction drives the decision to move beyond observation toward laser or photodynamic therapy.

4 Facts Exams Always Ask

Ink blot leakage is the most common fluorescein angiography pattern, smokestack leakage is classic but uncommon.
OCT shows optically clear subretinal fluid, often with a small pigment epithelial detachment and increased choroidal thickness with pachychoroid features on enhanced depth imaging.
Always ask about corticosteroid exposure by any route, even minimal or nonsystemic exposure counts.
Most acute CSCR resolves spontaneously with observation and risk factor modification, persistent disease beyond 3 months may warrant photodynamic therapy or focal laser in selected cases.

The Classic Trap

A common board exam pitfall is failing to ask about corticosteroid exposure in any form. Students often only screen for oral steroid pills and miss nasal sprays, inhalers, topical creams, or joint injections, all of which carry a documented association with CSCR. Dose and route do not eliminate risk, so any steroid exposure in the history should raise suspicion for CSCR in a young or middle aged patient with acute central distortion. Choroidal neovascularization should also be considered in chronic or atypical cases, particularly in older patients or when subretinal hemorrhage or exudation is present.

Clinical Pearl

Think of the RPE as a pump holding fluid out of the subretinal space. When choroidal pressure overwhelms that pump, fluid backs up under the retina exactly like a clogged drain overflowing. Laser treats focal leakage but does not correct the underlying choroidal abnormality, which is why photodynamic therapy is generally preferred for chronic disease. Fluorescein angiography is useful for identifying leakage sites, while OCT is the preferred test for diagnosis and monitoring.

Check yourself

Checkpoint 1

Which fluorescein angiographic leakage pattern is classically associated with CSC?

Checkpoint 2

Compared with fluorescein angiography, indocyanine green angiography in CSC is particularly useful for demonstrating what abnormality?

Clinical case

A 34-year-old male presents with two weeks of metamorphopsia and micropsia in one eye. He recently completed a course of intranasal corticosteroid spray for allergies. OCT shows a dome shaped area of clear subretinal fluid at the macula without hemorrhage. What is the most appropriate next step in management?

What is the most appropriate next step in management?

Explanation

For a first episode of acute central serous chorioretinopathy with a clear steroid trigger, the correct next step is observation and discontinuation of the corticosteroid exposure rather than immediate laser or photodynamic therapy. Anti-VEGF therapy is not routinely indicated unless secondary choroidal neovascularization develops. Laser photocoagulation or photodynamic therapy is reserved for cases that fail to resolve or recur, not for a fresh acute presentation with an identifiable trigger.

Case discussion

The corticosteroid history combined with painless central distortion, metamorphopsia, and clear subretinal fluid on OCT points to acute central serous chorioretinopathy. Since this is a first episode with a clear steroid trigger, the correct next step is observation and discontinuation of the corticosteroid exposure rather than immediate laser or photodynamic therapy. Anti-VEGF therapy is not routinely indicated unless secondary choroidal neovascularization develops. Laser photocoagulation or photodynamic therapy is reserved for cases that fail to resolve or recur, not for a fresh acute presentation with an identifiable trigger. Visual acuity often improves substantially, although recurrent episodes may lead to permanent retinal pigment epithelium and photoreceptor damage.

Sources & Reviewer Info

Reviewed by Vasilis Inglezis: Optometrist and Ocular Oncology Imaging Specialist, Ocular Oncology Center, Athens, Greece. Last updated July 27, 2026.

Diagram created with AI image generation, clinically reviewed for accuracy.

References

AAO EyeWiki. Central Serous Chorioretinopathy.
AAO Basic and Clinical Science Course (BCSC), Section 12: Retina and Vitreous.
Yannuzzi LA. Central Serous Chorioretinopathy.
Indian Journal of Ophthalmology. Central Serous Chorioretinopathy review.

Continue learning

Ready for the real thing?

Practice thousands of eye-care questions free on OcuQuiz. Earn points, build streaks and battle colleagues.

Practice Retina →